Tone Fokstuen

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 530 citations

Medicine, Oncology, Pharmacology +16

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

A.J. Breugom, W. van Gijn, E.W. Muller et al. · Annals of Oncology · 2014 · 393 citations · Full text

Medicine, Oncology, Surgery +17

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

Maxime J.M. van der Valk, Corrie A.M. Marijnen, Boudewijn van Etten et al. · Radiotherapy and Oncology · 2020 · 214 citations · Full text

Medicine, Oncology, Surgery +16

Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.

Geke A.P. Hospers, Renu R. Bahadoer, Esmée A. Dijkstra et al. · Journal of Clinical Oncology · 2020 · 110 citations

Medicine, Oncology, Surgery +17